RELENZA

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RELENZA contains one active pharmaceutical ingredient (API):

1 Zanamivir UNII L6O3XI777I - ZANAMIVIR

Zanamivir is a selective inhibitor of neuraminidase, the influenza virus surface enzyme. Neuraminidase inhibition occurred in vitro at very low zanamivir concentrations (50% inhibition at 0.64nM–7.9nM against influenza A and B strains). Read about Zanamivir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RELENZA Inhalation powder, pre-dispensed	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AH01	Zanamivir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AH Neuraminidase inhibitors
Discover more medicines within J05AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510606401171310
Country: CA	Health Products and Food Branch	Identifier(s): 02240863
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.405-12-06
Country: EE	Ravimiamet	Identifier(s): 1040083, 1265565
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62712
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 495820
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 41256
Country: HK	Department of Health Drug Office	Identifier(s): 45843
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250702G1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1023715, 1025823
Country: MT	Medicines Authority	Identifier(s): MA192/03001
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 378M99
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 66397
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8410
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100178060
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65857001, W65857002
Country: SG	Health Sciences Authority	Identifier(s): 11199P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522550180
Country: US	FDA, National Drug Code	Identifier(s): 0173-0681
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/20.2.8/0032